Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion type Assertion NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_head.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion description "[Interactions between MAGE-A4, LAGE1 and NY-ESO1 and their significant clinical consequences introduce these CTAs as appropriate targets for a polyvalent cancer vaccine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion evidence source_evidence_literature NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion SIO_000772 21613820 NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion wasDerivedFrom befree-20150227 NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.
- NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_assertion wasGeneratedBy ECO_0000203 NP965252.RAm64fJ0hhks4qajuVUVtW1LukssmK5qsXsIibeSYv2DU130_provenance.